Molecular Partners AG (MOLN)
5.285
-0.13
(-2.49%)
USD |
NASDAQ |
Nov 22, 16:00
5.31
+0.02
(+0.47%)
After-Hours: 20:00
Molecular Partners Price to Book Value: 1.180 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.180 |
| November 21, 2024 | 1.210 |
| November 20, 2024 | 1.161 |
| November 19, 2024 | 1.219 |
| November 18, 2024 | 1.302 |
| November 15, 2024 | 1.190 |
| November 14, 2024 | 1.172 |
| November 13, 2024 | 1.230 |
| November 12, 2024 | 1.271 |
| November 11, 2024 | 1.299 |
| November 08, 2024 | 1.384 |
| November 07, 2024 | 1.346 |
| November 06, 2024 | 1.393 |
| November 05, 2024 | 1.284 |
| November 04, 2024 | 1.352 |
| November 01, 2024 | 1.367 |
| October 31, 2024 | 1.197 |
| October 30, 2024 | 1.373 |
| October 29, 2024 | 1.384 |
| October 28, 2024 | 1.300 |
| October 25, 2024 | 1.306 |
| October 24, 2024 | 1.211 |
| October 23, 2024 | 1.141 |
| October 22, 2024 | 1.322 |
| October 21, 2024 | 1.364 |
| Date | Value |
|---|---|
| October 18, 2024 | 0.98 |
| October 17, 2024 | 1.002 |
| October 16, 2024 | 0.9961 |
| October 15, 2024 | 0.9961 |
| October 14, 2024 | 0.9558 |
| October 11, 2024 | 0.9558 |
| October 10, 2024 | 0.9558 |
| October 09, 2024 | 0.9872 |
| October 08, 2024 | 0.9872 |
| October 07, 2024 | 0.9578 |
| October 04, 2024 | 1.010 |
| October 03, 2024 | 0.9216 |
| October 02, 2024 | 0.9317 |
| October 01, 2024 | 0.9639 |
| September 30, 2024 | 1.024 |
| September 27, 2024 | 0.9725 |
| September 26, 2024 | 0.8996 |
| September 25, 2024 | 0.8861 |
| September 24, 2024 | 0.9619 |
| September 23, 2024 | 0.9072 |
| September 20, 2024 | 0.8957 |
| September 19, 2024 | 0.8957 |
| September 18, 2024 | 0.9283 |
| September 17, 2024 | 0.9744 |
| September 16, 2024 | 0.9993 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5405
Minimum
Oct 30 2023
8.774
Maximum
Jan 14 2022
1.838
Average
0.8953
Median
Feb 21 2023
Price to Book Value Benchmarks
| AC Immune SA | 2.162 |
| CRISPR Therapeutics AG | 2.107 |
| Addex Therapeutics Ltd | 0.5718 |
| NLS Pharmaceutics Ltd | -- |
| MoonLake Immunotherapeutics | 7.017 |
Price to Book Value Related Metrics
| PS Ratio | 25.67 |
| PEG Ratio | -0.3214 |
| Price | 5.285 |
| Earnings Yield | -40.52% |
| Market Cap | 194.69M |
| PEGY Ratio | -0.3214 |